HQL ETF

Screen 5,700+ ETFsFind similar ETFs with lower fees
See inside every fund you own
$99/yr Pro · Cancel anytime
X-ray my whole portfolio
Showing the top 10 of 131 holdings
Top 10 weight
43.43%
HQL top 10 holdings, by weight
#TickerNameWeightCumulative
1
REGN
Regeneron Pharmaceuticals Inc
7.35%		7.4%
2
AMGN
Amgen Inc
7.28%		14.6%
3
GILD
Gilead Sciences Inc
6.61%		21.2%
4
VRTX
Vertex Pharmaceuticals Inc
4.53%		25.8%
5
ALNY
Alnylam Pharmaceuticals Inc
3.45%		29.2%
6
BMRN
BioMarin Pharmaceutical Inc
3.44%		32.7%
7—Neurovance Milestone Interest
3.02%		35.7%
8
GVMXX
State Street Global Advisors
2.92%		38.6%
9
INSM
Insmed Inc
2.42%		41.0%
10
ARGX
Argenx SE
2.41%		43.4%
More holdings · Pro
FundXLS Pro
See the other 121 holdings of HQL
X-ray your whole portfolio and see every overlapping stock across your ETFs, mutual funds, and 401(k) holdings.
X-ray my whole portfolio$99/yr Pro · Cancel anytime

HQL ETF Top Holdings

HQL holdings top 10 positions. The top 10 holdings account for 43.4% of the fund, led by Regeneron Pharmaceuticals Inc at 7.4%, Amgen Inc at 7.3%, Gilead Sciences Inc at 6.6%.

HQL portfolio concentration is moderate, with the top 10 representing 43.4% of total assets.

HQL sector allocation provides a detailed breakdown. HQL overlap tool shows how holdings compare to other funds in your portfolio.

Compare HQL

HQL vs SPYHQL vs QQQHQL vs VOOHQL vs VTIHQL vs IVVHQL vs SCHDHQL vs VYMHQL vs VXUS
Showing 10 of 131 holdingsTop 10 Weight: 43.43%
#TickerNameIndustryWeightAllocation
1REGNRegeneron Pharmaceuticals IncUnknown7.35%
2AMGNAmgen IncUnknown7.28%
3GILDGilead Sciences IncUnknown6.61%
4VRTXVertex Pharmaceuticals IncUnknown4.53%
5ALNYAlnylam Pharmaceuticals IncUnknown3.45%
6BMRNBioMarin Pharmaceutical IncUnknown3.44%
7-NEUROVANCE MILESTONE INTERESTUnknown3.02%
8GVMXXState Street Global AdvisorsUnknown2.92%
9IM8NInsmed IncUnknown2.42%
10ARGXArgenx SEUnknown2.41%
Want to see all 131 holdings?

Holdings Distribution

Loading chart...